Newbridge Financial Services Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79
| Closed | -$82 | – | 1148 |
|
|
2024
Q3 | $82 | Hold |
79
| – | – | ﹤0.01% | 641 |
|
|
2024
Q2 | $137 | Sell |
79
-300
| -79% | -$520 | ﹤0.01% | 1056 |
|
|
2024
Q1 | $906 | Hold |
379
| – | – | ﹤0.01% | 1049 |
|
|
2023
Q4 | $1.26K | Hold |
379
| – | – | ﹤0.01% | 1006 |
|
|
2023
Q3 | $1.42K | Buy |
379
+79
| +26% | +$295 | ﹤0.01% | 1124 |
|
|
2023
Q2 | $1.28K | Buy |
+300
| New | +$1.28K | ﹤0.01% | 1188 |
|